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ABSTRACT 
 Hypoxia in the neonate is one of the leading causes of encephalopathy and 
seizures. Sadly, a significant subset of these children will acquire epilepsy, as their risk 
increases several-fold even with recovery from the initial encephalopathy. Epilepsy can 
be debilitating and potentially fatal, and can be considered as a condition of hyper-
excitable and hyper-synchronistic neural circuitry. Cellular and molecular changes 
consequent to neonatal seizure-inducing hypoxia are not fully understood, but multiple 
pro-epileptogenic candidate mechanisms exist. For example, acutely decreased 
inhibition has been shown at 1 hour post-hypoxia induced seizures, but it is unknown 
whether this effect is persistent.  Such persistent effects on inhibition could promote the 
development of epilepsy. We designed three specific aims to determine mechanisms of 
persistently decreased inhibition of area CA1 of the hippocampus following perinatal 
hypoxia-induced seizures. 
  Specific Aim One was to determine whether the acute (P10) decrease in GABA 
mediated inhibitory currents, IPSCs, persists beyond the initial 24 hours reported 
previously. We hypothesized that there would be a persistent increase in inhibition at 
least one week post hypoxia.  Whole-cell voltage-clamp data indicates persistently 
decreased action potential-dependent GABA-mediated inhibitory post synaptic currents 
that may possibly be due to decreased interneuron firing. 
Specific Aim Two was to determine whether there are persistent changes to the 
composition/expression of the GABAA receptor in hippocampus. We hypothesized that 
there would be persistent decreases in the overall expression and or composition of the 
iii 
 
GABAA receptor. Western blot analysis suggests that no change in the expression of α1, 
α2, β2/3 or γ2 GABAA subunits occurs, at any time point studied, following perinatal 
hypoxia-induced seizures. 
Specific Aim Three was to determine whether there are persistent changes in 
calcineurin expression/activity. We hypothesized that there would be an increase in 
hippocampal calcineurin expression and/or activity persistently following hypoxia-
induced seizures.  Western blot data suggests that no change in the expression of 
calcineurin occurs beyond the initial 24 hours post hypoxia-induced seizures previously 
reported. Furthermore, calcineurin activity did not increase at 24 hours and 48 hours post 
hypoxia-induced seizures. Preliminary data suggests activation of an alternative 
enzymatic pathway, possibly Interleukin-1 receptor dependent activation of casein 
kinase II, possibly contributing to altered GABAergic inhibition of area CA1 of the 
hippocampus. 
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CHAPTER I 
INTRODUCTION 
Significance 
The incidence of seizures is highest in the neonatal period and most commonly 
caused by hypoxic encephalopathy (Volpe 2001). Clinically, infants are exposed to 
hypoxia during a number of potential conditions, including perinatal asphyxia, 
respiratory arrest, near-miss sudden infant death syndrome, and during corrective heart 
surgery. Perinatal cerebral hypoxia greatly increases the risk of developing cerebral 
palsy, developmental delay and seizure disorders (Volpe 2001, Bernes and Kaplan 1994, 
Bergamasco et al 1984). Unfortunately, neonatal hypoxia induced seizures can be 
refractory to conventional anti-epileptic drug treatment. Understanding how perinatal 
cerebral hypoxia occurs and increases the susceptibility to develop epilepsy is critical if 
we hope to successfully treat seizures in this setting and prevent the sequence of events 
that lead to increased seizure susceptibility later in life.  
 In the early 1990s, researchers developed a neonatal animal model of global 
central nervous system hypoxia (Jensen et al 1991). This animal model replicates the 
human condition in key elements including; (ɪ) age dependent susceptibility to hypoxia 
induced seizures, (ɪɪ) refractoriness to anti-epileptic drug treatment, and (ɪɪɪ) long-term 
increases in seizures susceptibility (Rakhade et al 2011, Jensen et al 1991). In 2005, 
Sanchez et al, demonstrated that following hypoxia-induced seizures at P10, rats 
exhibited decreased frequency and amplitudes of GABA-mediated inhibitory post-
synaptic potentials (IPSCS) in CA1 hippocampal pyramidal neurons. Furthermore, 
2 
 
 
antagonism of calcineurin and or blockade of AMPA receptors (a type of glutamate 
receptor) caused an increase in the frequency and amplitudes of GABA-mediated 
inhibitory post synaptic currents in area CA1 of the hippocampus, apparently opposing 
the effects of hypoxia. During this same time period the phosphorylation of the β2/3 
subunit of the GABA receptor  was decreased suggesting that calcineurin may act on 
GABA mediated IPSCs by dephosphorylation of the GABAA receptors, causing 
increased internalization, and hence decreased amplitudes and frequency of IPSCs.  
Probably the most interesting aspect of this paper was that pre administration of FK-506, 
an antagonist of calcineurin, significantly inhibited hypoxia-induced perinatal seizures, 
emphasizing the importance of this pathway in this model.  
Many unknowns remain to be explored in this animal model. For example, 
whether or not GABA mediated inhibition remains persistently decreased beyond the 
first day following hypoxia-induced seizures is unknown. Furthermore, since acute 
changes occur in both amplitude and frequency of IPSCs, the potential for pre- and post-
synaptic mechanisms is probable. Finally, it remains to be determined whether 
calcineurin activity/expression remains increased. We have proposed 3 specific Aims to 
address these questions. 
Specific Aim One will determine whether the acute (P10) decrease in GABA 
mediated inhibitory currents, IPSCs, persists beyond the initial 24 hours reported 
previously (Sanchez 2005). We hypothesized that a persistent increase in inhibition 
would occur at least one week post-hypoxia. Specific Aim Two will determine whether 
there are persistent changes to the composition/expression of the GABAA receptor in 
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hippocampus. We hypothesized that a persistent decrease in the overall expression and 
or composition of the GABAA receptor would occur. Specific Aim Three will determine 
whether persistent changes in calcineurin expression/activity occur. We hypothesized 
that an increase in hippocampal calcineurin expression and/or activity would occur 
following hypoxia-induced seizures.  
The following chapters will contain a discussion of the results and the 
implications of those results in the context of increased seizure susceptibly in the rat 
model of hypoxia-induced seizures. The introductory chapter will explain, in more 
depth, the importance of each component of which this dissertation is focused, in order 
to better understand the unique nature of neonatal hypoxia-associated epilepsy. 
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Background 
Epilepsy 
Epilepsy is a common neurological disorder, affecting approximately 1% of the 
world’s population (Theodore et al 2006). Epilepsy is a pathological condition of 
hyperexcitable and hypersynchronous neural circuitry that manifests itself clinically as 
seizures. Seizures can cause neuronal cell loss, rewiring of neural circuitry, and 
redistribution of ion channels when excessive electrical activity occurs for long periods. 
This has been shown in numerous animal models and among others, altered GABAA and 
hyperpolarization activated cyclic nucleotide gated ion channels (HCN channels) may be 
involved in promoting epilepsy.  For example, the expression of HCN channel has been 
shown to be modified in many animal models of epilepsy (Chen 2001, Budde 2005, and 
Shah et al 2004). HCN2 knockout mice display an altered IH and an absence-like seizure 
phenotype (Ludwig et al 2003). Also, decreased neocortical HCN1 expression has been 
found to be associated with a rat genetic absence epilepsy model (Strauss et al 2004). 
Our laboratory recently showed that IH is attenuated in pyramidal neurons in a neonatal 
hypoxia model of epilepsy (Zhang et al 2006). Although several studies have indicated 
an indirect role of HCN channels in regulating inhibition (Macaferri and McBain 1996, 
Lupica et al 2001), this is beyond the scope of this dissertation. This dissertation will 
focus on direct regulatory GABAergic mechanisms.  
Alterations in GABAergic inhibition have been implicated in both human 
epilepsies and rat models of epilepsy. The expression and localization of several GABAA 
receptor subunits have been reported to be altered by seizures (. The functional 
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consequences of these alterations include changes in phasic and tonic GABA currents, as 
well as, alterations in pharmacological sensitivity to benzodiazepines (Mtchedlishviliet 
al 2001, Kapur and Macdonald 1997). Despite GABA’s well-established role in 
epilepsy, the regulatory mechanisms governing pathological GABAergic inhibition are 
still being elucidated. 
Neonatal Hypoxia 
As mentioned above, hypoxia in the neonate is one of the leading causes of 
encephalopathy and seizures (Volpe et al 1989) and a significant subset of these children 
will acquire epilepsy, as their risk increases five-fold even with recovery from the initial 
encephalopathy (Bergamasco et al 1984, Connell et al 1989, Volpe et al 1989).  Cellular 
and molecular neural changes consequent to neonatal seizure-inducing hypoxia are not 
fully understood, but multiple pro-epileptogenic candidate mechanisms exist.  In the 
early 1990s Jensen et al began characterizing an animal model of neonatal hypoxia-
induced seizures that mimics the acute and long-term epileptogenic effects of neonatal 
hypoxia observed clinically (Jensen et al 1991).  
Rat pups exposed to global hypoxia (5-7% O2 for 15 minutes) on postnatal day 
10 exhibit spontaneous seizures and later exhibit chronically increased seizure 
susceptibility. Hippocampal slices obtained from these animals several days after the 
hypoxia-induced seizures exhibit an increased propensity for electrographic seizure-like 
activity, thus providing a convenient in vitro preparation to identify cellular mechanisms 
that underlie this hippocampal hyperexcitability. For example, acutely decreased 
inhibition has been shown in slices 1 hour post-hypoxia induced seizures, but it is 
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unknown whether this effect is persistent (Sanchez et al 2005). Such persistent effects on 
inhibition could promote the development of epilepsy.  
Decreases of inhibitory neurotransmission could be due to several mechanisms 
including changes in the release of GABA from presynaptic stores, the 
composition/expression of the GABAA receptor, and the state of GABAA receptor 
modulation through various post-translational processes, especially calcineurin, a highly 
conserved Ca2+ and  calmodulin-dependent serine/threonine phosphatase, which has 
been shown to be acutely up-regulated after hypoxia-induced seizures (Sanchez et al 
2005). Altered GABAA receptor subunit expression and pharmacological sensitivity 
have been reported in neonatal, as well as, adult rodent models of seizures and human 
epileptic hippocampi (Zhang et al 2004, Schwarzer et al 1997, Bouilleret et al 2000, 
Raol et al 2006, Loup et al 2000). However, it is not known whether changes in 
expression of GABA receptor subunits occur following neonatal hypoxia-induced 
seizures.  
Calcineurin is a serine threonine specific phosphatase involved in many essential 
cellular processes. Calcineurin is a key phosphatase involved in neonatal hypoxia-
induced seizures, as demonstrated by an acute increase in calcineurin expression/activity 
following neonatal hypoxia-induced seizures and most importantly, blockade prevented 
hypoxia-induced neonatal seizures (Sanchez et al 2005). This increased calcineurin 
activity was associated with decreased phosphorylation of the β2/3 subunit of the 
GABAA (Sanchez et al 2005). Still, whether calcineurin expression/activity persists and 
whether post-synaptic changes occur to GABAA receptors are unknown. 
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Hippocampus 
The hippocampus, Greek for sea horse, is a specialized area of the brain whose 
main function is short-term memory processing. Since memory is involved with so many 
different types of human diseases and disorders including Alzheimer’s, epilepsy 
(including many pharmacologically intractable varieties), head injuries that cause 
amnesia and age associated memory loss, it is a very highly researched area of the brain. 
The basic circuitry of the hippocampus begins with the perforant pathway arising from 
the entorhinal cortex projecting glutamatergic synaptic boutons on the cell dendrites and 
soma of granule neurons lying in an area known as the dentate gyrus. These cells not 
only receive excitatory input from the entorhinal cortex but also GABAergic inhibitory 
synapses from hilar polymorophic neurons located within the hilus. The mossy fiber 
pathway is the next in this looping pathway also sending glutamatergic projections but 
this time from the dentate gyrus granule neurons to pyramidal neurons located in area 
CA3. These pyramidal neurons then send afferent glutamatergic projections to area CA1 
pyramidal neurons through an axonal pathway called the schaeffer collaterals. Excitatory 
principal cells in each region are under the control of local inhibitory GABA-secreting 
interneurons. In area CA1,pyramidal neurons receive inhibitory input primarily from 
stratum radiatum and stratum oriens. Finally, these CA1 pyramidal neurons send afferent 
projections through the subiculum back to the entorhinal cortex, completing a loop. This 
looping network, once compromised, can lead to high frequency synchronized 
oscillations of action-potential bursting groups of neurons innervating themselves 
through a polysynaptic feedback loop. 
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Interneurons of the Hippocampus  
The interneurons of the hippocampus, like the neocortex, are highly specialized 
and highly diverse class of neurons that provide inhibition to neural networks. Unlike 
their principal cell counterparts, these cells have highly diverse morphological and 
biochemical attributes. Interneurons are characterized by the synthesis and release of the 
neurotransmitter GABA and exert their inhibitory control on the activity of 
glutamatergic neurons through the activation of postsynaptic GABAA receptors, thereby 
creating inhibitory currents in their target cells. A number of interneurons of the 
hippocampus have been described based on numerous different criteria over the years. 
However, as researchers began to classify interneurons it was found that no single 
subtype could be definitively identified as many of the different markers used to separate 
them overlapped, and an adequate classification system that is universally accepted is 
still needed to this day (Buzsaki 2004, Baraban and Tallent 2004, Cossart 2005, Jonas  
2004). 
The morphological and physiological characteristics of adult hippocampal 
interneurons have been extensively reviewed (Freund and Buzsaki 1996, Somogyi and 
Klausberger 2005). GABAergic interneurons provide local feed-forward and feed-back 
inhibitory circuits. The axonal arborization of interneurons allows one interneuron to 
contact several hundreds of pyramidal neurons and provides them with the capability to 
synchronize the activity of glutamatergic neurons and therefore play a fundamental role 
in shaping the temporal pattern of various types of neural oscillations (Freund and 
Buzsaki 1996, Somogyi and Klausberger 2005). Hippocampal interneurons have been 
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classified into several subgroups according to their axonal projection pattern, rather than 
by cell morphology. Basket cells make synapses specifically with the cell bodies and 
proximal dendrites of principal cell, while chandelier or axo-axonic cells contact the 
axon initial segment of principal neurons (Somogyi et al 1983). Furthermore, basket 
cells establish synapses not only with the cell bodies and proximal dendrites of principal 
neurons but also with other basket cells (Fukuda and Kosaka 2000). Other interneurons 
target specific parts of the dendrites of pyramidal neurons. For example, oriens-
lacunosum moleculare(O-LM) cells are located in the stratum oriens but contact the 
distal-most part of the apical dendrites of pyramidal neurons in the stratum lacunosum-
moleculare. These various interneuron subtypes may differentially affect the activity of 
excitatory neurons. Inhibitory synapses on cell bodies or axon initial segments are 
ideally located to control the genesis of action potentials, while interneurons targeting 
the dendrites of pyramidal neurons may control dendritic calcium spikes (Miles et al 
1996). Interneurons with specific projection patterns also express particular calcium-
binding proteins or neuropeptides (Freund and Buzsaki 1996).  
GABA Receptors 
Many receptors are named after the primary activating agonist. This is mainly 
due to the historical context from which they were researched. For example, GABAA 
(and GABAC) and GABAB are related only by the activating agonist GABA, gamma 
amino butyric acid. Both receptor types are widely distributed, but differ both in modes 
of action and molecular composition. While GABAB nomenclature matches GABAA and 
GABAC, it is not part of the same superfamily. The GABAA receptor is the most widely 
10 
 
 
distributed and important inhibitory molecules in the central nervous system where it is 
responsible for IPSCs, inhibitory postsynaptic potential currents in many cell types from 
a diverse phylogenetic tree. Since the explosion of molecular techniques in the early 
1990s we now know that the GABAA system is a member of a superfamily proteins 
coined Cys-loop ligand-gated ion channels (LGIC), named for their characteristic loop 
formed by a disulfide bond between two cysteine residues. Members of this superfamily 
include nicotinic acetylcholine receptors, glycine receptors, as well as the GABAA 
receptor. All members of this superfamily are composed of 5 subunits that form 
heteromeric proteins with an integrated ion pore. In the case of the GABAA receptor, this 
ion pore conducts chloride ions following the binding of GABA. This increases the 
chloride conductance, providing an inhibitory current (and hyperpolarization of the 
membrane) to the neuron, that if great enough ceases action potential firing.  
GABAA Receptor Subunits 
GABAA receptors are members of the ligand-gated ion channel superfamily. The 
GABAA receptor protein is a pentamer with an integrated ion channel pore formed by 
the heteromeric assembly of various GABAA receptor subunits. Several subunits can 
combine to form pharmacologically distinct receptor subtypes. These subunits include 
the following, α1-6, β1-3, γ1-3, d, ε, π, θ, ρ1-3 (Simon et al 2004). Of most interest to 
our study are primary synaptic GABAA receptors that are composed of 2 α subunits, 2 β 
subunits, and a single γ subunit. Mutations of the genes that encode GABAA receptors 
have delitarious effects. For example, humans that have mutations in genes for these 
subunits suffer from various forms of epilepsy. 
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Benzodiazepines 
Status epilepticus is a syndrome consisting of a very prolonged seizure with 
continuous evolution of neurological state, worsening cerebral metabolism, a steady rise 
in core temperature, a rise in blood pressure, lactic acidosis, hyperglycemia and 
increased catecholamine levels (Simon et al 1984; Meldrum et al 1973).In humans, 
status epilepticus is treated with benzodiazepines, including diazepam, lorazepam, and 
midazolam and barbiturates, including phenobarbital and pentobarbital, all of which 
exert an anticonvulsant effect by acting on the GABA receptors (Macdonald and Kelly 
1995).Once bound to the GABAA receptor, diazepam locks the receptor protein complex 
into a conformation which has a greater affinity for the endogenous neurotransmitter 
GABA. This increases the frequency of the opening of the associated chloride ion 
channel and hyperpolarizes the membrane of the associated neuron thereby inhibiting the 
neuron and decreasing action-potential firing resulting in decreased neuronal network 
excitability. The net effect being anticonvulsant, sedatory and/or anxiolytic effects 
depending on the chemical structure of the benzodiazepine and specific combination of 
GABA receptor subunits, as well as the region of the brain affected. Interestingly, both 
in humans and in experimental animals, benzodiazepines are efficacious in early, but not 
late status epilepticus (Yaffe and Lowenstein 1993, Walton and Treiman 1988). Thus, 
both experimental animal and human data suggest that the functional properties of 
hippocampal GABA receptors are rapidly modified during status epilepticus. This 
refractoriness to diazepam resulted from the loss of diazepam potency but not of 
diazepam efficacy. These studies suggested that refractoriness of seizures to diazepam 
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may result from altered GABA receptor function in the hippocampus (Kapur et al 1989, 
Kapur and Macdonald 1996, 1997, Kapur and Coulter 1995, Lothman et al 1991, Van 
Landingham et al 1991). 
Benzodiazepines bind at the interface of α and γ GABAA receptor subunits. 
Diazepam sensitivity of GABA receptors requires the presence of the γ2 subtype with a 
β subtype and either α1, α2, α3, or α5 subtypes (Pritchett et al 1989, Macdonald and 
Olson 1994). Recombinant GABA receptors expressed without the γ2 subtype are highly 
sensitive to zinc (Zn), whereas GABA receptors expressed with the γ2 subtype are 
relatively insensitive to Zn (Draguhn et al 1990, Smart et al 1991). Therefore, one 
explanation for acute reduction of diazepam sensitivity of hippocampal dentate granule 
cell GABA receptors after seizures would be a loss of the γ2 subtype from the receptor; 
however this would not explain diminished Zn sensitivity of these receptors. Another 
potential explanation for diminished diazepam and Zn sensitivity would be an altered α 
subtype expression, because α subtypes are known to alter both Zn and diazepam 
sensitivity of the GABA receptors. More recently, GABAA receptor subunit specific 
surface trafficking has been shown in epileptic rats (Brooks-Kayal et al 1998). Seizures 
may alter GABA receptor function by other mechanisms such as posttranslational 
modification of GABA receptors or release of endogenous benzodiazepine-like 
substances. Modification of GABA receptors by phosphorylation is also well 
documented (Lin et al 1994, Macdonald and Olson 1994, MacDonald and Kelly 1995). 
For instance, seizures are known to modulate activity of calcineurin, which plays a role 
in GABA receptor function (Jope et al 1992, Perlin et al 1992). 
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Calcineurin 
Interestingly, calcineurin is acutely up regulated following hypoxia-induced 
seizures in the neonatal rat. In this model, rats postnatal day 10-13 are susceptible to 
hypoxia-induced tonic-clonic and myoclonic seizures that later predisposes the animal to 
a lower seizure threshold and spontaneous seizures.. Calcium influx through GLUR2 
negative AMPA receptors causes the acute activation of calcineurin, a highly conserved 
Ca2+ and calmodulin-dependent serine/threonine phosphatase. Following hypoxia-
induced seizures, CA1 pyramidal neurons exhibit a down-regulation of GABAA 
receptor-mediated inhibition with a concomitant dephosphorylation of the β2/3 subunit 
that was reversed by calcineurin inhibitors. This study did not explore any other possible 
effects that calcineurin may have had on other ion channels. Recently, calcineurin was 
reported to regulate the hyperpolarization-activated current (IH). 
 The pathological decrease in IH in CA1 pyramidal neurons maybe due post-
translational modification of the channel (Jung et al 2010). Acutely, calcineurin may 
cause dephosphorylation of the HCN channel (Jung et al 2010). However, this is 
unknown and the specific dephosphorylation site(s) have not been identified yet. 
Furthermore, the study associating calcineurin and IH modulation used FK506, which 
may directly modulate other ion channels (Jung et al 2010). Finally, this study did not 
refute the hypothesis that FK506 may act by dephosphorylation of another HCN 
regulating protein.  
 This dissertation aims to broaden the characterization of altered GABAergic 
inhibition and elucidate underlying molecular mechanisms. 
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CHAPTER II 
PERSISTENTLY DECREASED INHIBITION OF AREA CA1 OF THE 
HIPPOCAMPUS FOLLOWING PERINATAL HYPOXIA-INDUCING 
SEIZURES* 
Introduction 
Hypoxia is the most common cause of neonatal seizures and can lead to epilepsy, 
but the epileptogenic mechanisms are not yet understood. We have previously shown 
that hypoxia- induced seizures in the neonatal rat result in acutely decreased amplitudes 
and frequency of spontaneous and miniature inhibitory postsynaptic currents (sIPSCs 
and mIPSCs see appendixes A and B respectively) in hippocampal CA1 pyramidal 
neurons. In the current study, we asked whether such changes persist for several days 
following hypoxia-induced seizures. Similar to the acute findings, we observed 
decreased frequency and amplitudes of sIPSCs and decreased mIPSC amplitudes in CA1 
pyramidal neurons at 3–5 days after hypoxia. However, in contrast to the acute findings, 
we observed no differences between hypoxia-treated and control groups in mIPSC 
frequency. Additionally, by 7 days after hypoxia, sIPSC amplitudes in the hypoxia group 
had recovered to control levels, but sIPSC frequency remained decreased. These data 
indicate that the persistently decreased sIPSC frequency result from decreased firing of 
presynaptic inhibitory interneurons, with only transient possible changes in postsynaptic 
responses to GABA release. 
Cerebral hypoxia is the most common cause of neonatal seizures, and can lead to 
epilepsy, mental retardation, and cerebral palsy (Bergamasco et al 1984, Bernes and 
*Reprinted with permission from S. Karger AG, Medical and Scientific Publishers, Allschwilerstrasse 
10, 4009 Basel, Switzerland (Sanchez R.M. et al: Dev Neurosci 2007;29:159-167) 
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Kaplan 1994, Volpe 2001). Seizure-inducing global hypoxia in neonatal rats results in 
long-term increases in seizure susceptibility (Jensen et al 1991 and 1992) and can lead  
to learning deficits (Yang et al 2004), thus mimicking clinical aspects of neonatal 
hypoxia-induced seizures. Although such seizures in the neonate may be neocortical in 
origin, c-Fos immunocytochemistry several hours after hypoxia-induced seizures 
indicates involvement of the hippocampus (Jensen et al 1993), and electrophysiological 
studies in hippocampal slices from animals that experienced neonatal hypoxia-induced 
seizures have demonstrated consequent acute and chronic pathological increases in 
network excitability (Jensen et al 1998, Sanchez et al 2001). Thus, a single episode of 
hypoxia associated with seizures in the perinatal period can have adverse consequences 
for hippocampal function that may promote epileptogenesis, as well as disrupt cognitive 
function, in the long term.  
The mechanisms that critically contribute to hippocampal dysfunction after 
perinatal hypoxia-induced seizures are yet poorly understood, but likely include 
pathological changes in synaptic inhibition. Inhibitory signaling mediated by γ-
aminobutyric acid type A (GABAA) receptors has been observed to be altered in the 
hippocampus and neocortex by various mechanisms in several experimental seizure 
models (for a review, see Cossart et al 2005). In the immature brain specifically, the 
developmental pattern of GABAA receptor subunit mRNA expression was shown to be 
disrupted throughout the hippocampus as early as 6 h after kainate-induced status 
epilepticus in postnatal day 9 (P9) rats (Lauren et al 2005), and pilocarpine-induced 
status in P10 rats was found to alter GABAA receptor subunit mRNA expression and 
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GABAA receptor function in dentate granule cells into adulthood (Zhang et al 2004). 
Additionally, hyperthermia-induced seizures in P10 rats resulted in increased evoked and 
miniature GABAA receptor-mediated inhibitory postsynaptic currents (IPSCs) within 1 
week, changes that depend on pathological modulation of mechanisms that govern 
presynaptic GABA release (Chen et al 1999). Thus, although their precise contribution 
to possible hippocampal dysfunction and epileptogenesis remains under investigation, 
multiple mechanisms of GABA-mediated inhibition have been found to be 
pathologically altered acutely and chronically by seizures in the developing brain. 
 Using a rat model, we have previously demonstrated an acute decrease in basal 
synaptic inhibition of hippocampal area CA1 pyramidal neurons after hypoxia-induced 
seizures in the immature brain (Sanchez et al 2005). Specifically, we observed 
significantly decreased amplitudes and frequency of both spontaneous and miniature 
GABAA receptor-mediated IPSCs (sIPSCs and mIPSCs) in CA1 pyramidal neurons 
recorded in slices prepared 10 minutes after hypoxia-induced seizures at P10, and further 
found that these changes were associated with strong activation of the neuronal 
phosphatase calcineurin and dephosphorylation of GABAA receptors (Sanchez et al 
2005). Notably, previous work demonstrated that hippocampal slices prepared as early 
as 10 minutes following hypoxia-induced seizures already exhibit hyperexcitability in 
area CA1 (Jensen et al 1998). Thus, perinatal hypoxia-induced seizures can dysregulate 
hippocampal synaptic inhibition through very rapid biochemical events, and this 
dysregulation may help to promote an immediate pathological increase in network 
excitability. Given the persistence of hippocampal hyperexcitability after hypoxia-
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induced seizures, however, these early biochemical events must precede more permanent 
changes that are likely mediated by mechanisms other than kinase/ phosphatase 
signaling. 
 In the current study, we asked whether the acutely decreased basal synaptic 
inhibition of CA1 pyramidal neurons after hypoxia-induced seizures in P10 rat pups 
could be observed several days after hypoxia treatment, as we had previously found 
pathologically increased hippocampal excitability to persist during this period (Sanchez 
et al 2001). Our findings indicate that decreased inhibition persists for at least 1 week 
following hypoxia-induced seizures. However, whereas the immediate decreases may 
depend on both pre- and postsynaptic changes, the longer-lasting decrease appears to be 
mediated largely by pathologically decreased spontaneous firing of presynaptic 
inhibitory interneurons.  
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Methods 
Animals 
Long-Evans rat pups (Charles River), at an age of P10–P17, were used for these 
experiments. Litters were housed with their dam in the UTHSC (University of Texas 
Health Science Center at San Antonio) animal facility on a 12-hour light/12-hour dark 
cycle. All procedures were approved by the Institutional Animal Care and Use 
Committee and were in accordance with NIH guidelines on the ethical use of 
experimental animals.  
Hypoxia Treatment 
Seizures were induced in male Long-Evans rat pups on P10 by a 14–16-minute 
exposure to 5–7% O2. Pairs of littermates were removed from their dam and each placed 
into a custom-made airtight chamber on heating pads to maintain a rectal temperature of 
33–34° C. One chamber (control) was left uncovered and continuously exposed to room 
air, while the other (hypoxia) was covered and the O2 concentration lowered by infusion 
of nitrogen gas into the chamber. The O2 concentration was lowered to 6–7% for 4 
minutes, then 5–6% for 8 minutes, and then lowered by 1% per minute until the animal 
became apneic for 30 seconds. The chamber was then uncovered and exposed to room 
air.  
Using this protocol, spontaneous seizures typically began within 2–4 minutes of 
hypoxia, and occurred repeatedly throughout the hypoxia duration until apnea, and most 
animals continued to exhibit behavioral seizures for several minutes after returning to 
room air. At the end of hypoxia treatment, both animals in a pair were ear-marked with 
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sharp scissors and returned to their dam. Thus, control animals were handled identically 
to hypoxia-treated animals except for hypoxia exposure. All animals in the hypoxia-
treated group used for this study exhibited a minimum of three tonic-clonic seizures. 
Hippocampal Slice Preparation 
Hippocampal slices were prepared 3–7 days after hypoxia treatment. Rat pups 
were killed by decapitation under isoflurane anesthesia. The brains were removed and 
immediately placed into ice-cold oxygenated artificial cerebrospinal fluid (ACSF) that 
contained (in mM): sucrose 201, KCl 3.2, Na2PO4 1.25, MgCl2 2, CaCl 2 2, Na2HCO3 
26, and D-glucose 10, bubbled with 95% O2 /5% CO2. The brains were blocked by 
making a razor cut along the coronal plane just anterior to the cerebellum, and the cut 
end was glued to the stage of a vibratome (Leica 1000 S). Coronal sections (350 µM) of 
slices were cut in cold, continuously oxygenated sucrose ACSF, and then incubated for 
at least 1 h in a custom-made holding chamber filled with continuously oxygenated 
recording ACSF that contained (in mM): NaCl 126, KCl 3.3, Na2PO4 1.25, MgSO4 1.3, 
CaCl2 2, Na2HCO3 26, and D-glucose 10, bubbled with 95% O2 /5% CO2 at room 
temperature. 
Electrophysiological Recordings 
Slices were transferred to a submersion chamber (Warner Instruments) that was 
superfused continuously with oxygenated ACSF at room temperature for recordings. 
Whole-cell patch-clamp recordings were obtained from CA1 pyramidal neurons under 
visual guidance using infrared differential interference contrast microscopy (Zeiss 
Axioskop FS2 with a Dage-MTI camera). The standard recording pipette solution 
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contained (in mM): Cs-gluconate 123, NaCl4, MgCl2 2, EGTA 10, HEPES 10, Na-ATP 
4, GTP 0.3, pH 7.2. For experiments to study GABA-mediated currents at –70 mV, we 
used a pipette solution with approximately equimolar chloride to the extracellular 
solution that contained (in mM): CsCl 129, MgCl2 2, EGTA 10, HEPES 10, Na-ATP 4, 
GTP 0.3, pH 7.2. Filled recording pipettes had resistances of 1–3 megaohms, and series 
resistances were less than 20 megaohms. 
 Voltage clamp recordings were obtained using a Multiclamp 700A amplifier 
(Axon Instruments) and digitized with a Digidata 1322A (Axon) for acquisition to 
computer. Data were filtered at 2 kHz and digitized at 10 kHz. Input resistance and 
series resistance were monitored intermittently throughout experiments by applying –10 
mV voltage steps and observing the capacitative transient of the current response. Input 
resistances ranged from 540 to 800 megaohms and did not differ significantly between 
groups.  
Initial series resistances were estimated to be less than 20 megaohms, and data 
were discarded if series resistance changed by more than 30%. sIPSCs and mIPSCs were 
detected and analyzed off-line using Mini-Analysis (Synaptosoft) on a Windows-based 
computer, or using the event detection package with a variable amplitude template in 
Axograph 4.9 (Axon) on a Macintosh computer. Detected events were visually scanned 
and obvious artifacts were excluded. For sIPSCs, the first 500 events, and for mIPSCs, 
the first 150–200 events detected for each cell were used for analysis. Complex events 
(consisting of two or more IPSCs) detected by Mini-Analysis were included in the 
analyses of inter-event intervals and amplitudes (the Mini- Analysis algorithm calculates 
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event amplitudes from a baseline determined by the extrapolated decay of the preceding 
event), but were excluded from analyses of rise and decay times. Given the somewhat 
subjective nature of spontaneous event detection, these analyses were corroborated using 
Axograph 4.9 by a second experimenter blinded to the experimental condition. 
Exponential fits to averaged IPSCs were done using Igor Pro Carbon (Wavemetrics).  
Except where noted, the numbers of cells given in statistical analyses represented 
one cell per animal. NBQX (1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-
sulfonamide),APV(DL-2-amino-5-phosphonovaleric acid), bicuculline and tetrodotoxin 
(TTX) were diluted from stock solutions to final concentrations in ACSF and applied by 
bath superfusion. All drugs were purchased from Sigma. 
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Results 
sIPSC Amplitudes and Frequency Remain Decreased Days after Hypoxia-Induced 
Seizures 
We initially examined sIPSCs in CA1 pyramidal neurons in hippocampal slices 
prepared 3–5 days after hypoxia treatment, and in slices from age-matched littermate 
control-handled animals. IPSCs were recorded at a holding potential of +10 mV, the 
approximate reversal potential for glutamate receptors, so that spontaneous GABAergic 
events could be isolated without blocking excitatory transmission in the slice. Figure 1 
shows outward sIPSCs recorded under these conditions. The identification of these as 
GABAA receptor-mediated synaptic currents was confirmed by their complete blockade 
with 20 µM bicuculline at the end of experiments (not shown). As illustrated in figure 1, 
at 3–5 days after hypoxia, we observed a significant decrease in both the amplitudes and 
frequency of sIPSCs. Mean sIPSC amplitudes in the hypoxia-treated group were 
significantly diminished to 63.7% of control (mean amplitudes = 19.89 8 2.2 pA for the 
control group; 12.67 8 1.4 pA for the hypoxia group; n = 10 per group; p = 0.013, 
Student’s t test), and the mean sIPSC frequency was decreased to 63.8% of control 
(mean frequency = 3.56 ± 0.26 Hz for the control group; 2.27 ± 0.32 Hz for the hypoxia 
group; p = 0.006). No differences in rise times were observed between groups (10– 90% 
rise times = 2.81 ± 0.11 ms for the control group; 2.92 ± 0.19 ms for the hypoxia group; 
p = 0.63). These data indicate that the acute decrease in basal synaptic inhibition persists 
at least for several days after hypoxia-induced seizures. We next examined possible pre- 
and post-synaptic mechanisms that maybe involved with this decrease in inhibition. 
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Decreased mIPSC Amplitudes but Not Frequency Days after Hypoxia-Induced Seizures  
We next examined mIPSCs under the same conditions by adding 1 µ M TTX to 
the bath. Similarly to sIPSCs, the mIPSC amplitudes were significantly decreased in the 
hypoxia-treated group    to  65.8%  of control  (figure2; mean mIPSC  amplitudes = 
18.36 ± 2 pA for the  control  
 
 
Figure1. sIPSCs. Basal synaptic inhibition of CA1 pyramidal neurons is decreased at 3-
5 days after hypoxia-induced seizures at P10. A1. An example of sIPSCs recorded by 
whole-cell voltage clamping of a control hippocampal area CA1 pyramidal neuron. A2. 
sIPSCs from pyramidal cell recorded from the hypoxia-treated group. Insets a and b 
show expanded 10- second segments from each of the longer traces. Summary data are 
illustrated by the bar graphs in B. sIPSC amplitudes and frequency were significantly 
decreased (*P=0.013 and 0.006 respectively).There was no difference in sIPSC rise 
times between groups. 
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group, n = 7; 12.08 ± 0.9 pA for the hypoxia group, n = 8; p = 0.01). However, in 
contrast to sIPSCs, the frequency of mIPSCs after hypoxia was 97.6% of control, and 
was not significantly different from the control group (mean mIPSC frequency = 1.02 ± 
0.13 Hz for the control group; 1.0  ±  0.06  Hz for  the  hypoxia  group;  p = 0.84). The 
finding of unchanged mIPSC frequency suggested that at 3–5 days after hypoxia there 
were no persistent changes in the number of  GABAergic synapses or in the probability 
of GABA release at inhibitory synapses.  
 
Figure 2: mIPSCSs. mIPSCs recorded 3-5 days after hypoxia-induced seizures 
exhibited decreased amplitudes compared to sIPSCs, but there was no difference in 
mIPSC frequency between groups. A. Sample raw traces of mIPSCs. B. Summary data 
for mIPSC amplitudes (left) and frequency (right). P= 0.04.  
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These observations further suggested that the decreased sIPSC frequency at this phase 
resulted from decreased spontaneous firing of presynaptic inhibitory interneurons, and 
not from altered release mechanisms at the presynaptic terminals. Conversely, decreased 
sIPSC and mIPSC amplitudes likely resulted from altered responses of postsynaptic 
GABAA receptors to synaptic GABA release. 
 Pharmacological Sensitivity of Postsynaptic GABAA Receptors Is Unchanged 
 To further characterize possible alterations in postsynaptic GABAA receptor 
properties at 3–5 days after hypoxia, we next examined their kinetics and 
pharmacological sensitivity. Notably, previous work by others showed that kainate-
induced status epilepticus in neonatal (P9) rats resulted in decreased γ2 mRNA 
expression throughout the hippocampus as early as 6 hours and at 3 days following 
kainate treatment (Lauren et al 2005). Given that the γ2 subunit confers benzodiazepine 
sensitivity, this suggested that decreased benzodiazepine sensitivity might be an early 
consequence of neonatal seizures (Sieghart et al 1999). To examine this possibility, we 
recorded mIPSCs 3–4 days after hypoxia treatment at a more physiological holding 
potential of –70 mV with glutamate receptors blocked by NBQX (20 µM ) and APV (50 
µM ), and with 1 µM TTX in the bath. As shown in figure 3, mIPSCs recorded under 
these conditions again exhibited decreased amplitudes in the hypoxia-treated group to 
67.2% of control (mean amplitudes = 44.1 ± 4 pA for the control group, n = 6 cells from 
4 animals; 30.14 ± 4.3 pA for the hypoxia group, n = 5 cells from 4 animals; p = 0.04, 
Student’s t test) with no differences in rise times (10–90% rise times = 0.93 ± 0.11 ms 
for the control group; 1.02 ± 0.14 ms for the hypoxia group; p = 0.6). mIPSC decays 
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were well fit by a single exponential function, and decay time constants estimated from 
these fits indicated no significant differences between groups despite a trend toward 
increased decay times in the hypoxia-treated group compared to controls (decay time = 
25.6 ± 2.4 ms for the control group; 33.2 ± 4 ms for the hypoxia group; p = 0.15). As 
shown in figure 3, application of the positive GABAA receptor modulator diazepam (200 
nM) significantly prolonged mIPSC decay times in both groups. There was no difference 
in the percent increase in decay times between the control and hypoxia-treated groups 
(percent increase = 48 ± 7.2 for the control group; 48.7 ± 8 for the hypoxia group). 
Though not exhaustive, these data indicate that the pharmacological and kinetic 
properties of postsynaptic GABAA receptors were unchanged at 3–4 days following 
hypoxia-induced seizures, and suggest that any changes in postsynaptic GABAA receptor 
properties were likely not due to altered subunit composition.  
Recovery of sIPSC Amplitudes but Not Frequency at 7 Days after Hypoxia 
To further characterize the time course of changes in sIPSC parameters following 
hypoxia-induced seizures, we again recorded sIPSCs at a holding potential of +10 mV in 
CA1 pyramidal neurons in slices obtained at 7 days after hypoxia-induced seizures at 
P10. As shown in figure 4, by 7 days sIPSC amplitudes in the hypoxia treated group had 
recovered to 93.7% of control (sIPSC amplitudes = 33 ± 1.8 pA for the control group; 
30.9 ± 3.4 pA for the hypoxia group; n = 4 per group; p = 0.61). However, sIPSC 
frequency remained consistently decreased in the hypoxia-treated group at 64.4% of 
control (sIPSC frequency = 7.1 ± 0.64 Hz for the control group; 4.57 ± 0.79 Hz for the 
hypoxia group; p = 0.048). This divergence confirmed that the decrease in sIPSC 
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amplitude was mediated by different mechanisms than those responsible for the 
decreased sIPSC frequency, and further suggested that the decrease in sIPSC frequency 
may be a chronic consequence of perinatal hypoxia-induced seizures. 
Since this article was published we have begun to explore possible mechanisms 
of persistently decreased sIPSC frequency following neonatal hypoxia-induced seizures. 
To this date, we have identified two antiepileptic drugs that counter this effect. 
 
 
 
 
Figure 3: No Change in Diazepam Sensitivity.  mIPSCs recorded at a holding 
potential of -70mV at 3-5 days after hypoxia-induced seizures exhibited decreased 
amplitudes with no changes in rise and decay times and responsiveness to diazepam. A. 
The traces shown are averages of 50 mIPSCs from sample neurons in control and 
hypoxia-treated groups under each condition. B. Bar graphs showing summary data for 
all cells. mIPSC amplitudes again were significantly smaller in hypoxia-treated group 
compared to controls (*P=0.04). No differences were observed between groups in rise 
and decay times and in the enhancement of decay times by 200 nM diazepam.  
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Figure 4: Persistently Decreased sIPSC Frequency. sIPSC amplitude and mIPSC 
frequencies recover by 7 days post hypoxia-induced seizures (P10) but sIPSC frequency 
remains decreased to approximately 60% of control. 
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Conclusions 
 
Our previous work demonstrated an acute decrease in both the amplitudes and 
frequency of sIPSCs and mIPSCs in CA1 pyramidal neurons recorded in slices prepared 
immediately following perinatal hypoxia-induced seizures in vivo (Sanchez et al 2005). 
In the current study, we examined further the ‘subacute’ time course of these changes at 
3–5 and 7 days after hypoxia. We observed that the decreases in sIPSC frequency and 
amplitudes persisted at 3–5 days after hypoxia. Additionally, mIPSC amplitudes 
remained decreased at this time, comparably to the decrease in sIPSC amplitudes. 
Interestingly, however, mIPSC frequency recovered to control levels. This last finding is 
significant in that it indicates that several days following neonatal hypoxia-induced 
seizures, basal synaptic inhibition of CA1 pyramidal neurons is decreased despite no loss 
of GABAergic synapses or apparent long-lasting changes in the probability of 
spontaneous GABA release.  
Although we did not record directly from presynaptic interneurons, this indicates 
that the persistent decrease in sIPSC frequency is most likely entirely due to decreased 
spontaneous firing of interneurons that provide synaptic inhibition to CA1 pyramidal 
neurons. Notably, a similar (yet not identical) scenario has been reported for layer II 
neurons of the entorhinal cortex at 3–7 days after pilocarpine-induced status epilepticus 
in adult rats (Kobayashi et al 2003) (see below).Examination of the pharmacological and 
kinetic properties of mIPSCs at 3–5 days after hypoxia also indicated no changes in 
these, although there was a trend toward longer decay times in the hypoxia-treated 
group. These properties of GABAA receptors can be post-translationally modulated, but 
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are largely determined by their specific subunit composition (Hevers and Luddens 1998, 
Mehta and Ticku 1999, Sieghart et al 1999), and dramatic changes in GABAA receptor 
subunit expression have been observed in hippocampal neurons acutely and chronically 
after neonatal status epilepticus in rats (Zhang et al 2004, Lauren et al 2005). The lack of 
significant changes at 3–5 days after hypoxia-induced seizures is thus consistent with a 
lack of altered GABAA receptor subunit expression in this seizure model, and suggests a 
posttranslational mechanism of IPSC amplitude down-modulation. 
Our previous work indicated that dephosphorylation of postsynaptic GABAA 
receptors was at least partly responsible for decreased amplitudes and increased decay 
times of sIPSCs immediately following hypoxia induced seizures, and further showed 
that calcineurin expression was significantly increased in the hippocampus at 24 hours 
after hypoxia, suggesting a persistence of increased calcineurin signaling (Sanchez et al 
2005). It is conceivable that the decreased amplitudes and trend toward increased decay 
times of mIPSCs we observed at 3–5 days after hypoxia in the current study reflected a 
persistent increase in basal calcineurin-mediated dephosphorylation of GABAA 
receptors, although we have yet to explore this as a possible mechanism during this 
phase. GABA-mediated synaptic inhibition of principal neurons has been reported to be 
pathologically altered in multiple neuron types in several experimental seizure models 
(Cossart et al 2005).  
Whereas many studies have focused on seizure-induced changes in GABAA 
receptor subunit expression and function (Clark et al 1994, Gibbs et al 1997, Schwarzer 
et al 1997, Tsunashima et al 1997, Brooks-Kayal et al 1998) or loss of GABAergic 
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neurons (Andre et al 2001, Dinocourt et al 2003,  Kobayashi and Buckmaster 2003, 
Sloviter et al 2003), recent work has underscored the importance of the regulation of 
intrinsic excitability and spontaneous firing of GABAergic interneurons (Kobayashi and 
Buckmaster 2003, Shao and Dudek 2005), in addition to mechanisms of GABA release 
(Chen et al 1999; Hirsch et al 1999), in controlling network excitability. For example, 
(Shao and Dudek 2005) reported that mIPSC frequency in dentate granule cells was 
significantly decreased at 4–7 days (and remained so for 3 months) after kainate-induced 
status epilepticus, yet they observed no differences between groups in the frequency of 
sIPSCs. These authors proposed that increased spontaneous firing of GABAergic 
interneurons may have been a compensatory response to the loss of GABAergic 
synapses or decreased GABA release probability indicated by the lower mIPSC 
frequency. In contrast, (Kobayashi et al 2003) reported that at 3–7 days after pilocarpine-
induced status epilepticus, layer II entorhinal cortical neurons exhibited no changes in 
mIPSC frequency, but significantly decreased sIPSC frequency. These data were similar 
to our observations after hypoxia, and indicated a functional decrease in basal synaptic 
inhibition despite no apparent loss of GABAergic synapses or reduction in the 
probability of action potential-independent GABA release, which could be attributed to 
decreased spontaneous firing of presynaptic interneurons.  
Although dysregulation of GABAergic transmission may be a general 
consequence and mechanism of seizure and epileptogenesis, it clearly is not restricted to 
alterations that occur at GABAergic synapses, as the intrinsic excitability and synaptic 
drive of GABAergic neurons are dynamically regulated and can profoundly affect 
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inhibition. It is worth noting that (Kobayashi and Buckmaster 2003) reported no 
difference between control and pilocarpine-treated groups in mIPSC amplitudes (in 
addition to frequency), despite decreased sIPSC amplitudes in the pilocarpine treated 
group. The altered amplitudes of only action potential- dependent IPSCs suggested that 
changes in action potential-dependent synaptic GABA release could also have impacted 
sIPSC frequency.  
In our study, the comparable decreases in both sIPSC and mIPSC amplitudes at 
3–5 days after hypoxia are more consistent with a common (as yet unidentified) 
postsynaptic mechanism of altered amplitudes, and the decreased sIPSC frequency in the 
hypoxia-treated group was most likely due entirely to decreased spontaneous firing of 
GABAergic interneurons. The apparent recovery of sIPSC amplitudes but not frequency 
by 7 days after hypoxia also argues for separate mechanisms of modulation of these two 
IPSC parameters. These observations further suggest that decreased interneuron 
excitability, due to decreased excitatory synaptic drive and/or altered intrinsic membrane 
properties, may be a long-term consequence of neonatal seizures induced by hypoxia, 
and may contribute to the chronic increase in hippocampal excitability and seizure 
susceptibility. Whether this effect is truly chronic has yet to be investigated. However, 
given that depolarizing responses to GABA during this early postnatal period contribute 
to activity-driven maturational processes (Ben-Ari 2002), even transient alterations in 
pre- and postsynaptic GABAergic transmission may have chronic consequences for 
hippocampal function by profoundly altering physiological maturation, and one would 
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expect that the longer the duration of each pathophysiological alteration, the more 
profound will be the chronic consequences. 
 In summary, we have identified persistent decreases in basal inhibitory synaptic 
transmission to hippocampal CA1 pyramidal neurons up to 1 week following hypoxia 
induced seizures in P10 rat pups. Whereas the acute decreases identified previously may 
be mediated by mass activity of the phosphatase calcineurin and rapid dysregulation of 
pre- and postsynaptic components of inhibitory synaptic transmission (Sanchez et al 
2005), the persistent decrease appears gradually to depend more on decreased 
spontaneous firing of presynaptic inhibitory interneurons. Direct examination of the 
intrinsic membrane properties of GABAergic interneurons in hippocampi from animals 
that experienced neonatal hypoxia induced seizures may elucidate the underlying 
mechanism(s) of this decreased spontaneous activity, and ultimately determine if and 
how this contributes to epileptogenesis and other hippocampal pathologies in this 
setting. 
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CHAPTER III 
GABAA RECEPTOR SUBUNIT EXPRESSION FOLLOWING PERINATAL 
HYPOXIA-INDUCING SEIZURES 
Introduction 
          The GABAA receptor is the most widely distributed and important inhibitory 
receptor in the central nervous system where it mediates, inhibitory postsynaptic currents 
in many cell types. The GABAA receptor is a member of a superfamily of proteins 
coined Cys-loop ligand-gated ion channels (LGIC), named for their characteristic loop 
formed by a disulfide bond between two cysteine residues. Members of this superfamily 
include 5-HT3 receptors, nicotinic acetylcholine receptors, glycine receptors, as well as 
the GABAA receptor. All members of this superfamily are composed of 5 subunits that 
form heteromeric proteins with an ion pore. In the case of the GABAA receptor, this pore 
conducts chloride following the binding of GABA.  
          This increases the chloride conductance and hyperpolarizes the membrane, 
thereby blocking action potential firing. There are several different subunits that impart a 
great deal of pharmacologically distinct receptor subtypes. These subunits include the 
following, α1-6, β1-3, γ1-3, d, ε, π, θ, ρ1-3 (Simon et al 2004). Of most interest to our 
study are synaptic GABAA receptors that are composed of 2 α subunits, 2 β subunits, 
and a single γ subunit. 
           Humans that have mutations in these genes for these subunits suffer from various 
forms of epilepsy. A decrease in γ2 subunits has been associated with decreased 
benzodiazepine and zinc (Zn) sensitivity in acquired partial epilepsy models (Houser et 
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al 2012), and thus, decreased  γ2 could suggest additional changes to the endogenous 
activity-dependent regulation of inhibition that are more complex. Changes in GABAA 
receptor subunit expression could explain our finding of transiently decreased IPSC 
amplitudes reported in chapter II, especially if the subunit expression follows the same 
time course. Such a finding would warrant further electrophysiological and 
pharmacological experiments to determine the functional consequences of altered 
GABAA receptor subunit expression. Here we examined the expression of several 
GABAA subunits involved with synaptic GABAA receptors, specifically α1, α2, β2/3, 
and γ2.  
          We hypothesized, based primarily on our findings of decreased IPSC amplitudes 
as far out as 5 days following neonatal hypoxia-induced seizures, that there would be 
decreased expression of the GABAA receptor subunits listed above. 
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Methods 
Animals 
Long-Evans rat pups (Charles River), at an age of P10–P16, were used for these 
experiments. Litters were housed with their dam in the TAMHSC animal facility in 
Temple, TX. Animals were kept on a 12-hour light/12-hour dark cycle. All procedures 
were approved by the Institutional Animal Care and Use Committee and were in 
accordance with NIH guidelines on the ethical use of experimental animals.  
Hypoxia Treatment 
Seizures were induced in male Long-Evans rat pups on P10 by a 14–16-minute 
exposure to 5–7% O2. Pairs of littermates were removed from their dam and each placed 
into a custom-made airtight chamber on heating pads to maintain a rectal temperature of 
33–34° C. One chamber (control) was left uncovered and continuously exposed to room 
air, while the other (hypoxia) was covered and the O2 concentration lowered by infusion 
of N2 gas into the chamber. The O2concentration was lowered to 6–7% for 4 minutes, 
then 5–6% for 8 minutes, and then lowered by 1% per minute until the animal became 
apneic for 30 seconds. The chamber was then uncovered and exposed to room air. Using 
this protocol, spontaneous seizures typically began within 2–4 minutes of hypoxia, and 
occurred repeatedly throughout the hypoxia duration until apnea, and most animals 
continued to exhibit behavioral seizures for several minutes after returning to room air. 
At the end of hypoxia treatment, both animals in a pair were ear-marked with sharp 
scissors and returned to their dam. Thus, control animals were handled identically to 
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hypoxia-treated animals except for hypoxia exposure. All animals in the hypoxia-treated 
group used for this study exhibited a minimum of five tonic-clonic seizures. 
Tissue and Sample Preparation 
Animals from 2 groups (hypoxia-vs.-control) at 3, 6 and 7 days post-hypoxia for 
a total of 6 groups were sacrificed at the same time each day. Rat pups were killed by 
decapitation under isoflurane anesthesia. The brains were removed and immediately 
placed into ice-cold oxygenated (with 95% O2 / 5% CO2) artificial cerebrospinal fluid 
(ACSF) that contained (in mM): NaCl 126, KCl 3.3, Na2PO4 1.25, MgSO4 1.3, CaCl22, 
Na2HCO3 26, and D-glucose 10.The hippocampi were quickly dissected and placed into 
ice cold 1x RIPA buffer complete with protease inhibitors. The hippocampi were rapidly 
homogenized by sonification with brief quick pulses while on ice. A Bradford 
colorometric assay was performed on all samples. The samples were aliquoted and 
stored at -80°C until Western blots were performed. 
Western Blot 
Antibodies were acquired from various vendors but most were acquired from the 
Ticku laboratory in San Antonio at UTHSCSA. We thank Dr. Ticku’s laboratory for 
kindly providing us with access to his antibody supplies. Western blot analysis of α1, α2, 
β2/3 and γ2 GABAA receptor subunit expression were conducted on whole hippocampal 
homogenates from 2 groups at 3 different time points: 24 hours, 48 hours and 6 days 
post-hypoxia (6 group’s total).  Samples were run on ready-made gels (BIORAD 
anyKD) at 200 Volts for 40 minutes. Transfer to PVDF membrane was performed at 90 
volts for 90 minutes in an ice bath.  
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The blots were then blocked with Licor blocking solution 1x for a minimum of 2 
hours at room temperature. Blots were incubated overnight with primary antibodies to 
GABAA receptor subunits (SOURCE)at 1:500-1:1000 dilutions and 1:10000 dilution 
anti-GAPDH (SOURCE). We used enhanced chemiluminescence for detecting most of 
the GABAA subunits, but detection of the β2/3 subunit was performed using both ECL 
and Licor. The quality of Licor Western blots is much greater than that of ECL and we 
performed separate β2/3 Western blots for both technologies and found no difference in 
the result. Optical density for each band was then measured by NIH software ImageJ. 
Finally, each band was background subtracted and normalized to GAPDH. 
 Normalized data were analyzed by student’s t-test or ANOVA where 
appropriate. We found no significant changes in the expression of any of the GABAA 
receptor subunits at any of the time points studied by either statistical method. 
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Results 
          To characterize possible alterations in postsynaptic GABAA receptor subunit 
expression we examined several GABAA receptor subunits known to mediate most 
postsynaptic GABA mediated currents called IPSCs. 
GABAA α1 Receptor Subunit Expression 
          We measured at 3 days post hypoxia-induced seizures (P13) the GABAA subunit 
α1. As can be seen in figure 5, there are no statistically significant changes in the 
expression of α1 following neonatal hypoxia-induced seizures at P13.  p = 0.40, 
Student’s t test. Since GABA receptors are composed of several different types of 
subunits, we further examined the most common subunits found in area CA1 of the 
hippocampus. 
 
 
GABAA α2 Receptor Subunit Expression 
              P13 
Figure 5: Hippocampal GABAA α1 Subunit Expression. Samples were 
normalized to GAPDH. No significant change in α1 expression was found at 
P13. Student’s T-test P>0.05 N=5-7 animals. 
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          We measured at 3, 6 and 7 days post hypoxia-induced seizures (P13, P16, P17) the 
GABAA subunit α2. As can be seen in figure 6, there are no statistically significant 
changes in the expression of α2 following neonatal hypoxia-induced seizures at P13.  p = 
0.40, ANOVA. We next looked at the β2/3 subunit known to be responsible for binding 
GABA to the receptor itself. 
 
  
Figure 6: Hippocampal GABAA α2 Subunit Expression. Samples were 
normalized to GAPDH. No significant change in α2 expression was found at 
P13. ANOVA  P>0.05 N=5-7 animals. 
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GABAA Receptor β2/3 Subunit Expression 
          We measured at 3 and 7 days post hypoxia-induced seizures (P13 and P17) the 
GABAA subunit β2/3. As can be seen in figure 7, there are no statistically significant 
changes in the expression of the GABAA receptor subunit β2/3 following neonatal 
hypoxia-induced seizures at P13, P16, P17. Student’s t test p=0.38. We next looked at 
the γ2 subunit known to play a key role in benzodiazepine regulation of the GABAA 
receptor. 
 
 
 
Figure 7: Hippocampal GABAA β2/3 Subunit Expression. Samples were 
normalized to GAPDH. No significant change in β2/3 expression was found at 
P13. ANOVA  P>0.05 N=5-7 animals. 
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GABAA Receptor γ2 Subunit Expression 
          We measured at 3 days post hypoxia-induced seizures (P13) the GABAA subunit 
γ2. As can be seen in figure 8, there are no statistically significant changes in the 
expression of the GABAA receptor subunitγ2 following neonatal hypoxia-induced 
seizures at P13 and P17.  p=0.58 Student’s t test.  
 
 
  
 
 
Figure 8: Hippocampal GABAA γ2 Subunit Expression. Samples were 
normalized to GAPDH. No significant change in γ2 expression was found at 
P13. Students t-test  P>0.05 N=5-7 animals. 
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Summary 
 The combined Western blot results from all GABAA subunits suggest that there 
are no significant changes to the protein expression of the GABAA receptor (see figure 
9). Since, in chapter 2 we measured possible changes in diazepam sensitivity and found 
none, the data support the same conclusion, that there are no changes in subunit 
composition of the GABAA receptors in area CA1 of the hippocampus following 
neonatal hypoxia-induced seizures. 
 
  
Figure 9: GABAA SUBUNIT EXPRESSION.  Summary of hippocampal 
GABAA subunit expression. Samples were normalized to GAPDH. No 
significant change in subunit at any time point studied. ANOVA  P>0.05 N=5-7 
animals. 
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Conclusions 
           Altered GABAA receptor subunit expression and pharmacological sensitivity have 
been reported in neonatal as well as adult rodent models of seizures and human epileptic 
hippocampi (Zhang et al 2007, Schwarzer et al 1997, Bouilleret et al 2000, Raol et al 
2006, Loup et al 2000). Pyramidal neurons in the rat hippocampus express phasic 
GABAA receptors composed of 2αs 2βs and one γ subunit(s). Human patients with 
temporal lobe epilepsy display decreased GABAA receptor subunit expression in 
hippocampal neurons (Loup et al 2000). Although there is no substantial loss of neurons 
in the neonatal hypoxia rat model as in other models of acquired epilepsies there still 
may be changes in the expression of various GABAA receptor subunits, especially 
considering the decrease in IPSC amplitudes reported in chapter II.  
          We aimed to determine whether decreased inhibition after neonatal hypoxia-
induced seizures is associated with changes in expression of postsynaptic GABAA 
receptors. Based on acute changes in IPSC amplitudes, we hypothesized that α1, α2, 
β2/3, and γ2 subunit expression would be decreased after hypoxia-induced seizures, 
compared to age matched control littermates. Previously, we had shown that the chronic 
decreases of sIPSC frequency after hypoxia-induced seizures were likely due to 
decreased firing of presynaptic interneurons. However, we also observed that s- and 
mIPSC amplitudes were transiently decreased during this critical maturational window 
after hypoxia-induced seizures. Changes in GABAA subunit expression could explain 
our finding of transiently decreased s- and mIPSC amplitudes, especially if the subunit 
expression follows the same time course, decreasing initially but recovering by 7 days 
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post hypoxia-induced seizures. For example, a decrease in the γ2 subunit of the GABAA 
receptor has been associated with decreased benzodiazepine and zinc sensitivity in 
acquired partial epilepsy models (Houser et al 2012), and thus, decreased γ2 could 
suggest additional changes to the endogenous activity-dependent regulation of inhibition 
that are more complex. Such a finding would warrant further electrophysiological and 
pharmacological experiments to determine the functional consequences of altered 
GABAA receptor subunit expression.  
          Western blot analysis of key GABAA subunits is an important experiment to 
conduct and seizure-dependent changes in subunit expression have been reported in   
animal models of acquired epilepsy and epileptic humans. For example, GABA-
mediated synaptic inhibition of principal neurons has been reported to be pathologically 
altered in multiple neuron types in several experimental seizure models (Cossart et al 
2005). Importantly, although numerous studies have focused on seizure-induced changes 
in GABAA receptor subunit expression and function or loss of GABAergic neurons, 
much of the evidence is not from actual protein expression but rather changes in mRNA. 
Changes in GABAA subunit expression could explain our finding of transiently 
decreased IPSC amplitudes, especially if the subunit expression follows the same time 
course, decreasing initially but recovering by 7 days post hypoxia-induced seizures. We 
found no changes in the expression of α1, α2, β2/3, and γ2 GABAA receptor subunits up 
to a week following hypoxia induced seizures compared to age-matched littermate 
controls (See figure 9). Although this contradicts our hypothesis, the Western blot data 
confirms our finding of no change in diazepam sensitivity following hypoxia-induced 
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seizures and supports our conclusion that no change in GABAA subunit expression 
occurs following hypoxia-induced seizures. Finally, combined with our 
electrophysiology data, the Western blot data tends to support the concept that no 
significant changes in composition of the post synaptic GABAA receptor within the first 
few days following hypoxia-induced seizures. This strongly suggests a post-translational 
mechanism, such as enzymatic modification of GABAA channel function. For example, 
calcineurin was shown to be acutely up regulated and when blocked can overcome the 
loss of both IPSC amplitudes and frequency we report in chapter one. We will address 
calcineurin mediated regulation of GABAA receptor inhibition as reported in Chapter 4. 
          Although these findings are consistent with electrophysiology data reported in 
chapter II, it is possible that by using whole hippocampus homogenates, we lost the 
ability to detect regionally specific changes in protein expression. Another way to 
perform this experiment is by micro-dissecting out area CA1, since this is the area we 
have been recording and found our effects on GABAA mediated inhibition. Also, 
utilizing other methodological approaches such as FACS or the Nano-pro system could 
be performed in a cell specific manner. Thus, future experiments using more sensitive 
technologies could identify more subtle cell-specific mechanisms. Nonetheless, the 
combined electrophysiology and Western blot results suggest that persistently altered 
GABAA receptor expression is not a mechanism of decreased GABAergic inhibition in 
this setting. 
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CHAPTER IV 
THE ROLE OF CALCINEURIN IN DECREASED INHIBITION FOLLOWING 
NEONATAL HYPOXIA-INDUCING SEIZURES 
Introduction 
During postnatal day 10-13 rats are susceptible to hypoxia-induced tonic-clonic 
and myoclonic seizures that later predisposes the animal to a lower seizure threshold and 
spontaneous seizures. These hypoxia-induced seizures appear to depend on AMPA 
receptor activation, since pharmacological blockade prevents them. Interestingly during 
this time period, many AMPA receptors lack the GLUR2 subunit that confers calcium 
impermeability. Calcium influx through GLUR2 negative AMPA receptors causes the 
acute activation of calcineurin, a highly conserved Ca2+ and calmodulin-dependent 
serine/threonine phosphatase, which has been shown to be acutely up-regulated after 
pilocarpine- and hypoxia-induced seizures. Emphasizing the importance of the 
calcineurin pathway, a 30 minute pre-application of FK-506 blocked hypoxia-induced 
seizures (Sanchez et al 2005). Interestingly, following hypoxia-induced seizures, CA1 
pyramidal neurons exhibited a down-regulation of GABAA receptor mediated inhibition 
with a concomitant dephosphorylation of the β2/3 subunit that was reversed by the 
calcineurin inhibitor FK-506, suggesting a possible proepileptogenic mechanism. 
Furthermore, application of FK-506 increases both spontaneous IPSC amplitudes and 
frequency following hypoxia-induced seizures. 
   Calcineurin activity has been shown to be increased following other models of 
epilepsy. For example, in the rat pilocarpine model, calcineurin activity was found to be 
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increased as measured by the phosphorylation status of the protein DARPP-32, a specific 
substrate of calcineurin’s phosphatase activity (Jung et al 2010). Another pilocarpine 
study reported a significant status epilepticus-dependent increase in hippocampal 
calcineurin activity, as measured by dephosphorylation of p-nitrophenol phosphate. 
However, the increase in calcineurin activity was not associated with an increase in 
calcineurin enzyme levels (Kurz et al 2001). This suggests that the increase in enzyme 
activity may be due to another mechanism, such as post-translational modification of the 
enzyme, or increased Ca2+/CaM binding to the enzyme following SE (Kurz et al 2001, 
2008). This provides yet another possible mechanism of decreased inhibition of CA1 
pyramidal neurons by calcineurin and demonstrates the need to determine whether 
calcineurin activity increases following neonatal hypoxia-induced seizures. A persistent 
increase in calcineurin expression and/or activity following neonatal hypoxia-induced 
seizures may provide long lasting effects on inhibition of area CA1 of the hippocampus, 
as well as other areas of the brain, and may promote the development of epilepsy in 
susceptible individuals.  
In this study we aimed to determine whether or not calcineurin activity remained 
increased past the 24 hours reported previously (Sanchez et al 2005). Based on our 
finding of persistently decreased GABAergic inhibition reported in Chapter One above, 
we hypothesized that calcineurin expression and or activity remained increased beyond 
24 hours post hypoxia-induced seizures. Therefore, in this study we measured both 
calcineurin expression as well as activity following neonatal hypoxia-induced seizures. 
This was accomplished by western blot analysis of calcineurin and DARPP-32. 
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Methods 
Animals 
Long-Evans rat pups (Charles River), at an age of P10–P16, were used for these 
experiments. Litters were housed with their dam in the TAMHSC animal care facility 
Temple, Texas on a 12-hour light/12-hour dark cycle. All procedures were approved by 
the Institutional Animal Care and Use Committee and were in accordance with NIH 
guidelines on the ethical use of experimental animals.  
Hypoxia Treatment 
Seizures were induced in male Long-Evans rat pups on P10 by a 14–16-min 
exposure to 5–7% O2. Pairs of littermates were removed from their dam and each placed 
into a custom-made airtight chamber on heating pads to maintain a rectal temperature of 
33–34° C. One chamber (control) was left uncovered and continuously exposed to room 
air, while the other (hypoxia) was covered and the O2 concentration lowered by infusion 
of N2 gas into the chamber. The O2 concentration was lowered to 6–7% for 4 min, then 
5–6% for 8 min, and then lowered by 1% per minute until the animal became apneic for 
30 s. The chamber was then uncovered and exposed to room air. Using this protocol, 
spontaneous seizures typically began within 2–4 min of hypoxia, and occurred 
repeatedly throughout the hypoxia duration until apnea, and most animals continued to 
exhibit behavioral seizures for several minutes after returning to room air. At the end of 
hypoxia treatment, both animals in the pair were ear-marked with sharp scissors and 
returned to their dam. Thus, control animals were handled identically to hypoxia-treated 
Figure 9: GABAA Subunit Expression.  Summary of hippocampal GABAA 
subunit expression. Samples were normalized to GAPDH. No significant 
change in subunit at any time point studied. ANOVA  P>0.05 N=5-7 animals. 
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animals except for hypoxia exposure. Animals in the hypoxia-treated group used for this 
study exhibited an average of eight tonic-clonic seizures. 
Tissue and Sample Preparation 
Animals from 2 groups (hypoxia-vs.-control) at 3 different time points – 24 
hours, 48 hours and 6 days post-hypoxia for a total of 6 groups were sacrificed at the 
same time each day. Rat pups were sacrificed by decapitation under isoflurane 
anesthesia. The brains were removed and immediately placed into ice-cold oxygenated  
(with 95% O2 / 5% CO2)  artificial cerebrospinal fluid (ACSF) that contained (in m M): 
NaCl 126, KCl 3.3, Na2PO4 1.25,  MgSO4 1.3, CaCl2 2, Na2HCO3 26, and D-glucose 10  
.The hippocampi were quickly dissected and placed into ice cold 1x RIPA buffer 
complete with protease inhibitors. Both hippocampi were rapidly homogenized by 
sonification with brief quick pulses while on ice. A Bradford colorometric assay was 
performed on all samples. The samples were aliquoted and stored at -80C until Western 
blots were performed. 
Western Blots (calcineurin) 
Western Blot analysis of calcineurin expression was conducted on whole 
hippocampal homogenates from 2 groups at 3 different time points: 24 hours, 48 hours 
and 6 days post-hypoxia (6 group’s total).  Samples were run on ready-made gels 
(BIORAD anyKD) at 200 Volts for 40 minutes. Transfer to PVDF membrane was 
performed at 90 volts for 90 minutes in an ice bath. The blots were then blocked with 
Licor blocking solution 1x for a minimum of 2 hours at room temperature. Primary anti-
rabbit Calcineurin antibody (obtained from Sigma) 1:1000 and mouse anti-GAPDH 
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antibody 1:10,000 was then used and the blot was allowed to incubate overnight at 4 
Degrees Celsius with constant movement. Optical density for each band was then 
measured by NIH software ImageJ. Finally, each band was background subtracted and 
normalized to GAPDH. Normalized data were then analyzed by ANOVA. 
Western Blots (DARPP-32) 
          Western Blot analyses of total DARPP-32 to phosphorylated DARPP-32 THR34 
and SER97 were conducted on whole hippocampal homogenates from 2 groups at 3 
different time points – 24 hours, 48 hours and 6 days post-hypoxia (6 groups total). 
Samples were run on ready-made gels (BIORAD anyKD) at 200 Volts for 40 minutes. 
Transfer to nitrocellulose membrane was performed using the BIORAD Trans-Blot 
Turbo Transfer System. The blots were then blocked with Licor blocking solution 1x for 
a minimum of 2 hours at room temperature. Primary anti-rabbit DARPP-32 antibody 
(obtained from Cell Signaling Technologies) at 1:1000 dilution, primary anti-rabbit 
phospho (THR34) DARPP-32 (obtained from Cell Signaling Technologies)1:1000 
dilution, primary anti-rabbit phospho (SER97)DARPP-32 (obtained from Cell Signaling 
Technologies) 1:1000 dilution and anti-mouse α-tubulin (Sigma) antibody 1:15,000 
dilution was then used and the blot was allowed to incubate overnight at 4 Degrees 
Celsius with constant movement. Secondary antibodies were used at room temperature 
for 30 minutes anti-rabbit 680 CW (Licor) and anti-mouse 800 CW (Licor) 1:20,000. 
Optical density for each band was then measured by NIH software ImageJ. Finally, each 
band was then background subtracted and normalized to α-tubulin. Normalized data was 
then analyzed by 2-way ANOVA. 
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Results 
Calcineurin Expression 
We measured the protein expression of calcineurin by Western blot analysis. As 
illustrated by figure 10, only the first 24 hours post hypoxia-induced seizures did 
calcineurin expression remain increased (P11 n= 17 control group and hypoxia group, 
p=0.0007;  P12 n=12 control group and hypoxia group, p=0.63; P17 n=10 control group 
and hypoxia group p=0.91). This result matches the results published previously by the 
Jensen laboratory (Sanchez 2005) Since an increase in the expression of calcineurin does 
not necessarily result in increased activity, we also measured the phosphorylation status 
of Threonine 34 (THR34) of DARPP-32 which is directly dephosphorylated by 
calcineurin and used as a measure of calcineurin enzymatic activity in previously 
published studies (Jung 2010).  
Calcineurin Activity (Threonine 34 Phosphorylation Status of DARPP-32 [THR34]) 
The Western blot results for THR 34 phosphorylation failed to support our 
hypothesis of increased calcineurin activity. Interestingly we found no calcineurin 
specific dephosphorylation of THR34 ofDARPP-32, but instead we found a mild 
increase (1.5-1.8 fold) in THR 34 PHOSPHO-DARPP-32 in the hypoxia group (See 
figure 11). The number of animals used in this study were; P11 n= 7 control group and 
n=7 hypoxia group, P12 n=4 control group and n=5 hypoxia group. A 2-way analysis of 
variance ( 2 Way-ANOVA) was used to analyze statistical significance between control 
and hypoxia as well as days post hypoxia-inducing seizures on P10 (hypoxia treatment 
p=0.012, no age-dependence).  
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Figure 10: Calcineurin Expression. Summary of calcineurin expression. ANOVA was 
used to analyze results. Calcineurin expression increased at 24 hours post hypoxia-
induced seizures and recovered by 48 hours post hypoxia-induced seizures and remained 
so at 6 days post hypoxia-induced seizures. P< 0.01 (N=17-18 each group). 
 
DARPP-32 (Regulation of Threonine 34 Phosphorylation via Serine 97 Phosphorylation 
Status [SER 97]) 
Phosphorylation of DARPP-32 at SER97 indirectly increases the phosphorylation of 
THR34 by protein kinase A (Hamada et al 2005). Therefore, we also measured SER97 
phosphorylation using Western blot analysis. At the same time points, we found a mild 
but significant increase in SER97 phosphorylation in the hypoxia group as well (see 
* 
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figure 12). The number of animals used in this study were; P11 n=8 control group and 
n=5 hypoxia group, P12 n=4 control group and n=4 hypoxia group. A 2-way analysis of 
variance (ANOVA) was used to analyze statistical significance (hypoxia treatment 
p=0.006, no age-dependence). 
 
 
Figure 11: Threonine-34 DARPP-32. The ratio of THR34 phospho-DARPP-32 to total 
DARPP-32 within each sample is significantly increased following hypoxia-induced 
seizures at 24 hours and up to 48 hours post hypoxia-induced seizures. * P<0.05 (N=5-6 
each group). 
* 
* 
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Figure 12: Serine-97 DARPP-32. Summary of average ratio of phosphorylated Serine 
97 of DARPP-32 to total DARPP-32 within each sample. The ratio of Serine 97 of 
phospho-DARPP-32 to total DARPP-32 within each sample is significantly increased 
following hypoxia-induced seizures at 24 hours and up to 48 hours post hypoxia-induced 
seizures. * P<0.05 (N=5-6 each group).   
 
 
 
 
 
 
* 
* 
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Conclusions 
An acute increase in calcineurin expression has been reported to coincide with a 
decrease in the phosphorylated form of the β2/3 subunit of the GABAA receptor 
(Sanchez et al 2005). This was interpreted as a decrease in the functional membrane 
associated GABAA receptor and maybe responsible for the acutely decreased IPSCs we 
recorded from P10-P11 animals. It was not known whether or not calcineurin expression 
remained increased beyond P11. Since we reported changes in GABAergic inhibition up 
to a week post-hypoxia, we focused on measuring calcineurin expression from P11-P17. 
The mechanisms by which hypoxia may increase calcineurin expression and or activity 
most likely differs short term (24 hours) versus long term (7 days). Since it would 
require translation of a significant amount of enzyme in a relatively short amount of 
time, it is unlikely that the short term effects are due to increased calcineurin protein 
expression.  For example, no increase in total calcineurin protein concentration was 
detected by Western blot analysis of cerebellum, cortex or hippocampus homogenates 
taken from rats 60 minutes post pilocarpine-induced seizures compared to age-matched 
controls from rats 60 minutes post pilocarpine-induced seizures, compared to age-
matched controls (Kurz et al 2001). Short-term increases in calcineurin activity may 
occur due to pathological loss of Ca2+ homeostasis and chronic stimulation of 
converging Ca2+ enzymatic pathways that either directly or indirectly activates the 
catalytic and or regulatory domains of the calcineurin molecule. 
 Calcineurin is a Ca2+ and calmodulin-stimulated serine/threonine phosphatase. 
The enzyme consists of two subunits, a catalytic subunit and a regulatory subunit. The 
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catalytic subunit, calcineurin A, contains two auto-inhibitory domains. Calcineurin B is 
the regulatory subunit that binds Ca2+ (Klee et al 1998). Calcineurin is inhibited by 
phosphorylation at the same location by both protein kinase C and CaM kinase II 
(Hashimoto and Soderling 1989, Martensen et al. 1989). Both calcineurin and CaM 
kinase II share a similar distribution in the brain supporting the notion of CaM kinase II 
regulation (Sola et al. 1999). Calcineurin regulates NFAT-mediated and CREB-mediated 
gene transcription important in modulating the function of both the GABA and the 
NMDA receptors, affects cytoskeletal architecture through dephosphorylation of 
microtubules and associated proteins, regulates neurotransmitter release, and may be 
involved in the initiation of apoptosis (Ankarcrona et al 1996, Huang and Dillon 1998, 
Krupp et al 2002, Goto et al 1985, Cordeiro et al 2000). All of these processes may play 
a role in the pathology of SE.  
More recently, calcineurin has been implicated in modulating HCN channel 
function (Jung et al 2010). Calcineurin expression has been shown to increase following 
pilocarpine and hypoxia-induced seizures. Furthermore, FK-506 a calcineurin 
antagonist, was demonstrated to reversibly inhibit seizures in neonatal hypoxia and 
amygdaloid kindled rats and ascomycin prevented seizures at higher dosages (Kurz et al 
2001; Sanchez et al 2005, Vazquez-Lopez et al 2006). It has also been demonstrated 
calcineurin activity is enhanced in hippocampal area CA1 from chronically epileptic 
animals, and that pharmacological reversal of this abnormal phosphorylation signaling 
restores pyramidal neuron excitability to control levels (Jung et al 2010). Recently, 
calcineurin was implicated in the regulation of dendritic spines via dephosphorylation of 
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cytoskeletal actin (Kurz et al 2008). Dendritic spines are small projections of the 
membrane located on the dendrites of neurons, which are thought to be a critical 
modulatory compartments of neurotransmission that provide increased surface area for 
synaptic connectivity and a relatively isolated compartment for modulation, especially 
Ca2+-dependent enzymatic pathways. Dendritic spine loss has been shown to occur in 
both human epilepsy and animal models of epilepsy (Muller et al 1993, Isokawa 1998, 
Isokawa and Levesque 1991, Multani et al 1994). Interestingly, both our report of 
decreased GABA currents, but also our decrease in IH following hypoxia-induced 
seizures can be explained by increased calcineurin expression/activity. One thing to note 
is that IH is functionally decreased after kainate-induced status epilepticus in adult rats 
but is increased after hyperthermia-induced seizures in immature rat pups, suggesting a 
possible age-dependence and/or conditional response. It is unknown whether this up-
regulation of calcineurin expression and or activity persists beyond 24 hours, thus 
promoting persistent changes in inhibition.  
We hypothesized that calcineurin expression and/or activity would increase 
persistently in the hypoxia-induced seizures group as compared to age-matched control 
littermates. However, we found that calcineurin expression did not increase beyond 24 
hours post hypoxia-induced seizures. Furthermore, calcineurin activity did not increase, 
as measured by specific dephosphorylation of THR 34 of DARPP-32. Although this 
does not support our hypothesis, it does open up the possibility of other key players 
previously not reported in this model of epilepsy.  
By further exploring DARPP-32 regulation via Serine 97 (SER97) 
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phosphorylation, we found that the possibility of  a protein kinase A (PKA)/casein 
kinase II (CKII) dependent phosphorylation of SER97 existed at 24 hours to 48 hours 
post hypoxia-induced seizures. Since, it was shown that SER97 phosphorylation 
increases protein kinase A-dependent phosphorylation of THR34, our finding of 
increased phosphor-THR34 at the 24 and 48 hour time point coincided with that of 
phosphor-SER97 and suggests that the increase in THR34 phosphorylation, and hence 
increased inhibition of protein phosphatase-1 (PP1), may not be due to an increase in 
protein kinase A activity (or decrease in calcineurin) but rather through an alternative 
pathway that may involve Interleukin-1 (IL-1), receptor activation and casein kinase II 
regulation of the SER97 site of DARPP-32. Although, it is unclear what is mediating the 
increase in THR34 phosphorylation, the functional consequence of increased phosphor-
THR34 DARPP-32 is increased inhibition of PP1 which regulates various receptors and 
channels such as voltage-gated Ca2+ and NMDA. 
Although increased calcineurin activity was reported in our neonatal model of 
hypoxia-induced seizures it was not done so by measuring phosphorylation changes on 
THR34 of DARPP-32 as used by Poolos and others, but rather by enzymatic assay (Jung 
et al 2010, Sanchez et al 2005). Furthermore, the increased activity of calcineurin was 
interpreted as direct (or DARPP-32 independent) dephosphorylation of β2/3 of GABAA 
receptors as reported previously and not by a DARPP-32 dependent regulation of PP1, 
which is known to be an important regulator of numerous ion channels that affect 
excitation and inhibition, possibly causing an imbalance when regulation becomes 
dysregulated following an insult such as hypoxia-induced seizures. Furthermore, we 
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have data to suggest that IL-1β, the major endogenous ligand of the IL-1 receptor, 
increases at 24 hours remaining so for several days following hypoxia-induced seizures 
compared to age-matched control animals. This is significant because we show that, 
when IL-1β is applied to hippocampal slices from control animals, both spontaneous 
IPSC frequency and amplitude decrease. Although speculative, combined with the data 
presented here, suggest that, increased IL-1 receptor activation by key players such as 
IL-1β could cause a decrease in inhibition as measured by sIPSCs in area CA1 of the 
hippocampus causing an imbalance of excitation and inhibition. Also, since this occurs 
over a period of days, this abnormal signaling, through several different pathways, 
including the IL-1 receptor and casein kinase II pathways, could contribute to the 
development of spontaneous seizures and epilepsy in the neonatal hypoxia model. 
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CHAPTER V 
SUMMARY AND CONCLUSIONS 
Introduction	  
An imbalance between excitation and inhibition has long been thought to 
underlie epilepsy. Previously, our laboratory and the laboratory of Frances Jensen 
reported an acute decrease in both the amplitudes and frequency of mIPSCs  and sIPSCs   
in CA1 pyramidal neurons recorded  in slices prepared immediately following perinatal 
hypoxia-induced seizures in vivo (Sanchez et al 2005). Decreases of GABergic 
inhibitory neurotransmission (IPSCs) could be due to several different mechanisms 
including: (1) Changes in the release of GABA from presynaptic stores (2) The 
composition/expression of the GABAA receptor and (3). The state of the GABAA 
receptor modulation through various post-translational processes, especially calcineurin, 
a highly conserved Ca2+ and calmodulin-dependent serine/threonine phosphatase, which 
has been shown to be acutely up-regulated following neonatal hypoxia-induced seizures 
(Sanchez et al 2005). Persistently decreased GABAergic inhibition could promote the 
development of epilepsy, epileptogenesis.  
In this study, we tested several hypotheses. One, does the acute (P10) decrease in 
GABA mediated inhibitory currents, IPSCs, persist? We hypothesized based on several 
lines of evidence, including the fact that rats exposed to hypoxia-induced seizures 
exhibit chronic increases in excitability in area CA1 of the hippocampus which is the 
final hippocampal region in a 3 circuit pathway that begins in the entorhinal cortex, that 
there would be a persistent increase in GABAergic inhibition. Two, are there persistent 
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changes to the composition/expression of the GABAA receptor? We hypothesized that 
there would be persistent decreases in the overall expression and or composition of  the 
GABAA receptor, based  primarily on our report of acutely decreased IPSC amplitudes, 
which could be due to changes in composition or expression of GABAA receptor 
subunits (mechanism 2 above). Three, are there persistent changes in calcineurin 
expression/activity following neonatal hypoxia-induced seizures? We hypothesized that 
there would be a persistent increase in calcineurin expression and or activity following 
neonatal hypoxia-induced seizures. This last hypothesis was based mainly on the 
observation that when calcineurin is blocked with FK-506 acutely (P10) sIPSC 
frequency and amplitudes increase providing yet another mechanism by which 
GABAergic inhibition maybe down regulated (mechanism 3 above). 
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Hypotheses 
Hypothesis 1 
In the current study, we hypothesized that there would be persistent changes in 
GABAA mediated inhibition in the hippocampus. We studied specifically, the fast phasic 
inhibition provided by synaptically-located GABAA receptors, those containing 2 αs 2βs 
and a γ subunit(s), and not δ subunit containing extra-synaptic GABAA receptors 
responsible for tonic inhibition. Although it is possible that tonic GABA currents are 
compromised and contribute to increased excitability of area CA1 pyramidal neurons 
following hypoxia-induced seizures, tonic GABAA receptor currents do not contribute 
to the decrease in IPSCs studied in chapter 2. The data supported our hypothesis, 
revealing a persistent decrease in GABAA mediated currents, IPSCs, which are regulated 
by both pre- and post-synaptic mechanisms. We found decreases in: action-potential 
dependent, sIPSC frequency and amplitudes that persisted at 3–5 days after hypoxia. 
This finding could be due to several different possible mechanisms. The decrease in 
sIPSC frequency could be due to differences in firing rates of presynaptic interneurons 
and the sIPSC amplitudes could be due to changes in the state of modulation by post-
translation processes, especially calcineurin activity/expression that has been shown to 
be pathologically increased following hypoxia-induced seizures (and modulates both  
sIPSC frequency but also sIPSC amplitude) (Sanchez et al 2005). The fact that there is 
no change in the mIPSC frequency but only a change in sIPSC frequency supports the 
hypothesis that during P13-P15 there are significantly less action-potential firing of 
interneurons and release of GABA. 
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Changes in sIPSC amplitude could be due to presynaptic changes in the amount 
of GABA released, the efficacy of GABA at the GABAA receptor, and possibly changes 
in either composition or expression of GABAA receptors. We found that action-potential 
independent mIPSCs were decreased in amplitude, but not frequency. 3-5 days post- 
hypoxia, mIPSC amplitudes were decreased and comparable to the decrease in sIPSC 
amplitudes. This supports the hypothesis that there are post- synaptic changes to the 
GABAA receptor, perhaps either by expression and/or composition of the GABAA 
receptor itself. We continued to look at this decrease in GABA mediated inhibition out 
to 7 days post-hypoxia-induced seizures and we found a recovery of action-potential 
independent frequency and amplitude, as well as action-potential dependent amplitudes. 
Interestingly, since mIPSC frequency recovered but not sIPSC frequency, only the 
action-potential driven IPSC frequency changed persistently out to 7 days post-hypoxia-
induced seizures and possibly longer. Combined with the recovery of both sIPSC and 
mIPSC amplitudes, this indicated that several days following neonatal hypoxia-induced 
seizures, basal synaptic inhibition of CA1 pyramidal neurons is decreased despite no 
apparent long-lasting changes in the probability of spontaneous GABA release, 
indicating that the persistent decrease in sIPSC frequency is most likely due to decreased 
spontaneous firing of interneurons that provide synaptic inhibition to CA1 pyramidal 
neurons. Still, since we do find changes in sIPSC and mIPSC amplitudes 3-5 days post 
hypoxia there could be changes in the composition/expression of the GABAA receptor 
itself which provided us with further rationale to analyze this possibility. For hypothesis 
2 we used a combination of techniques. 
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Hypothesis 2 
We utilized two methodological approaches in order to explore the possibility 
that there were changes in the composition and or expression of GABAA receptors 
following neonatal hypoxia-induced seizures. We looked both at the functionality of the 
GABAA receptor by electrophysiology and by measuring total protein of various 
GABAA receptor subunits that are known to be synaptically located in area CA1 of the 
hippocampus. Altered GABAA receptor subunit expression and pharmacological 
sensitivity have been reported in neonatal as well as adult rodent models of seizures and 
human epileptic hippocampi (Zhang et al 2007, Schwarzer et al 1997, Bouilleret et al 
2000, Raol et al 2006, Loup et al 2000). For example, research studies of both humans 
with temporal lobe epilepsy (TLE) and in rodent models of TLE found reduced 
expression of GABA receptor α1 subunits and increased expression of GABAA receptor 
α4 subunits in the dentate gyrus of epileptic individuals (Brooks-Kayal et al 1998 and 
1999). In the adult rat model of pilocarpine-induced status epilepticus these subunit 
alterations are associated with diminished benzodiazepine sensitivity (Gibbs et al 1997; 
Brooks-Kayal et al 1998). When similar studies were performed at an earlier 
developmental time point (postnatal day 10), rat pups that experienced pilocarpine-
induced SE had significantly increased GABAA receptor α1 expression in dentate gyrus 
and enhanced benzodiazepine sensitivity (Zhang et al 2004). However, it was not known 
if there are changes in expression of GABAA receptor subunits following neonatal 
hypoxia-induced seizures.  
Since GABAA channels sensitive to diazepam require an α , β and a γ to function 
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correctly, any hypoxia-associated change in the prolongation of the decay time of GABA 
currents following diazepam application would suggest a change in the GABAA receptor 
subunit composition. We found no statistical difference in diazepam sensitivity between 
control and hypoxia groups at 3-5 days post-hypoxia. Furthermore, by Western blot, we 
found no significant changes in the expression of α1, α2, β2/3, and γ2 subunits of the 
GABAA receptor at numerous time points. The combined electrophysiological and 
Western blot data strongly suggest that no significant changes in the post-synaptic 
composition of the GABAA receptor during P13-P15. Other mechanisms of decreased 
GABAergic inhibition following neonatal hypoxia-induced seizures likely exist, such as 
post-translational modification of the GABAA receptor.  
Hypothesis 3 
In the neonatal hypoxia-induced seizure model, calcineurin was shown to have 
increased activity and blocking calcineurin with FK-506 increased sIPSC frequency and 
sIPSC amplitudes reversing the losses associated hypoxia-induced seizures at P10 
(Sanchez et al 2005). Furthermore, blocking calcineurin activity with FK-506 prevented 
hypoxia-induced seizures at P10. Persistent changes in calcineurin expression/activity 
have not been reported. Persistently increased expression/activity of calcineurin 
following hypoxia-induced seizures could persistently decrease GABAergic inhibition. 
Calcineurin expression/activity is known to modulate both IPSC frequency and 
amplitude, possibly by dephosphorylating the β2/3 subunit of the GABAA receptor and 
causing internalization of the receptor complex thereby decreasing the frequency and 
amplitudes of GABA mediated IPSCs. To explore the possibility of a persistent increase 
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in calcineurin activity/expression we used Western blot analysis of calcineurin 
expression and THR34 phosphorylation status of DARPP-32. DARPP-32 is specifically 
dephosphorylated on THR34 by calcineurin and has been used as a measure of 
calcineurin activity (Jung et al 2010). Since there were no apparent changes in GABAA 
subunit composition 3-5 days following hypoxia, we hypothesized that the GABAA 
receptors were being post-translationally modified by increased calcineurin 
activity/expression. As previously reported, we found that calcineurin expression was 
increased up to 24 hours following hypoxia (Sanchez et al 2005). However, we report 
that there were no significant changes in expression beyond the initial 24 hours (P10-
P11) and as far out as 6 days (P16) following hypoxia-induced seizures.   
Since, expression isn’t the only way calcineurin can increase its enzymatic 
activity, we measured THR34 phosphorylation of DARPP-32 which is a specific 
substrate for calcineurin. Increases in calcineurin activity should be measurable as a 
decrease in the ratio of phosphoTHR34 DARPP-32 to total DARPP-32. If our hypothesis 
was correct we should have found decreased phosphoTHR34 DARPP-32 to total 
DARPP-32. However, our Western blot analysis demonstrated that THR34 
phosphorylation was mildly increased (~ 150% control) following hypoxia-induced 
seizures, raising the question of whether protein kinase A or some other unknown 
mechanism may overcompensate for any calcineurin specific activity. Since THR34 is a 
direct and specific substrate of phosphorylation by protein kinase A, it is possible that 
protein kinase A activity expression may have increased. This may very well be the case, 
but a relatively recent paper reported that protein kinase A activity among other enzymes 
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were acutely increased but recovered by 12 hours following neonatal hypoxia-induced 
seizures (Rakhade et al 2008). We then asked, “Could there be another pathway involved 
in THR34 phosphorylation status?” 
Alternative Pathways 
DARPP-32 is regulated by numerous phosphatases and kinases that specifically 
and directly act at various phosphorylation sites and some of these sites can interact and 
affect the phosphorylation of others. Specifically, residue SER97 is directly 
phosphorylated by casein kinase II (Girault et al 1989). Furthermore, when residue 
SER97 is phosphorylated, phosphorylation of THR34 by protein kinase A increases 
several fold (Girault et al 1989). So it is possible that THR34 phosphorylation can be 
increased, independent of changes of both protein kinase A and calcineurin. We next 
explored the question of whether SER97 may also have increased in phosphorylation. 
We found that SER97 phosphorylation status was also increased following 
neonatal hypoxia-induced seizures (~ 160%).  Together with the calcineurin Western 
blot data, it is unlikely that our hypothesis of post-translational modification of the 
GABAA receptor by calcineurin exists beyond the initial 24 hours following hypoxia-
induced seizures (P10-P11). These findings question the validity of using THR34 
phosphorylation status of DARPP-32 as a measure of calcineurin activity as previously 
reported (Jung et al 2010). 
 However, it’s important to note that since the phosphorylation status of a 
number of residues and the enzymatic pathways that are involved in the regulation of 
DARPP-32 are highly characterized it permits us to explore alternate pathways that may 
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be compromised as a consequence of neonatal hypoxia induced seizures.  Although we 
do not know yet which particular enzymatic pathways are being activated to increase the 
phosphorylation of THR34 and SER97, the physiological consequence of this is that the 
phosphorylation of THR34 of DARPP-32 increases inhibition of  protein phosphatase 1 
(PP1) (Svenningsson et al 2004). PP1 interacts with numerous receptors and channels in 
the brain where it is expressed in neurons. PP1 is highly abundant in neurons, and 
following NMDA receptor activation, it is recruited to the receptor and associates with it 
by binding to specific targeting partners. There, it decreases NMDA receptor activity 
and synaptic strength by reducing the receptors open probability (Wang et al 1994). 
Furthermore, postsynaptic GABAA receptor currents in neostriatal medium spiny 
neurons are decreased in a D1 dopamine receptor/PKA/DARPP-32/PP1 signaling 
cascade targeting the phosphorylation of GABAA receptor β1subunits (Flores-Hernandez 
et al 2000). It is not known whether PP1 function is decreased following hypoxia-
induced seizures but our Western blot data of THR34 raises the possibility of decreased 
inhibition of PP1 via DARPP-32. Furthermore, whether NMDA receptor function maybe 
increased via decreased PP1 activity following hypoxia-induced seizures is yet to be 
determined. The implications of increased NMDA activity following neonatal hypoxia-
induced seizures include increased excitability and increased calcium signaling, both of 
which contribute to increased acute as well as persistent hyperexcitability of the 
hippocampal network and possibly epileptogenesis, in susceptible individuals. 
We identified SER97 as a specific and direct substrate of casein kinase II, raising 
the possibility of this pathway being involved. Casein kinase II is known to be activated 
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as a consequence of inflammation (Gaestel et al 2009). It is unknown whether casein 
kinase II is up-regulated following hypoxia-induced seizures but our Western blot data 
of SER97 suggests this as a possibility. Casein kinase II has also been shown to regulate 
NMDA receptor function (Lieberman and Mody 1999, Kimura and Matsuki 2008). 
Although casein kinase II is not u-pregulated in the kainite model of epilepsy (Wyneken 
et al 2001) an increase in either casein kinase II protein expression or casein kinase II 
enzymatic activity may increase following hypoxia-induced seizures since as discussed 
earlier each model of epilepsy have unique characteristics that depend on the age and 
area of the brain involved as two examples. 
Casein kinase II plays a key role in regulating interleukin-1, or IL-1, 
biosynthesis. Interestingly, our laboratory has found increases in the endogenous ligand 
of the IL-1 receptor, IL-1β, following perinatal hypoxia-induced seizures. Furthermore, 
by applying IL-1β to the bath and recording IPSCs from hippocampal slices in area CA1 
by whole-cell voltage clamp, an increase in both amplitude and frequency of IPSCs 
occurs, providing an alternative mechanism for decreased IPSC frequency and 
amplitudes following hypoxia-induced seizures. Much work must be done to further 
characterize the pathways that lead to increased phosphorylation of THR34 and SER97, 
as well as the downstream sequence of events that occur as a response to 
phosphorylation of THR34 and SER97.  It is important to note that the phosphatase for 
SER97 is unknown and may also be involved. The hypothetical pathways of DARPP-32 
regulation following neonatal hypoxia induced seizures are summarized in figure 13. 
Finally, by 7 days following hypoxia only sIPSC frequency remained decreased, 
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and this strongly suggests when combined with the rest of our data, that only the 
presynaptic firing of interneurons remained suppressed. Interestingly, our laboratory 
reported decreased IH in CA1 pyramidal neurons (Zhang et al 2006).  Since IH is known 
to regulate the intrinsic firing rate of spontaneously active interneurons (Maccaferri and 
McBain 1996) we measured IH in interneurons of area CA1 of the hippocampus in 
studies done outside the scope of this dissertation. We found that, of the cells recorded, 
only 85 percent expressed IH. Furthermore, of the cells recorded we found no change in 
IH.  
We still have much work to determine whether or not there are specific 
subpopulations of interneurons affected by hypoxia-induced seizures that respond by 
decreased firing. This experimental question is confounded by the fact that numerous 
different subtypes of interneurons exist in the hippocampus (See Introduction Chapter).  
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Figure 13: Hypothetical Model of DARPP-32 Regulation. Hypothetical model of 
DARPP-32 regulation following hypoxia-induced seizures. Green and yellow arrows: 
activation of an enzyme or in the case of SER97 to protein kinase A phosphorylation 
increase in activity of protein kinase A phosphorylation of THR34. Red line with blunt 
end: inhibition of Protein phosphatase 1. 
 
 
 
 
 
73 
 
 
	  	  Conclusions and Future Directions 
We have characterized altered inhibition after neonatal hypoxia as a likely pro-
epileptogenic consequence and have begun to elucidate underlying mechanisms. Future 
directions of our laboratory include: determining the functional consequences of THR34 
phosphorylation of DARPP-32 in the rat model of neonatal hypoxia-induced seizures 
and determining how action potential-dependent GABAergic inhibition is altered 
following hypoxia-induced seizures and whether this decrease persists beyond 7 days 
following hypoxia, and determining how from 0 –5 days following hypoxia GABA 
mediated IPSC amplitudes decrease. Even though our data seem to suggest that the 
decrease in GABA IPSC amplitudes are not due to changes in the GABAA receptor 
expression/composition and that calcineurin expression/activity does not persist beyond 
the initial 24 hours post-hypoxia-induced seizures it is possible that internalization of the 
GABAA receptor is still occurring through another enzymatic pathway (perhaps CK2 or 
PP1 for example). 
 The next, and  simplest, experiment is to use an assay for surface expression of 
GABAA receptors. This can be accomplished by using biotin to label proteins that are 
located on the extracellular side of the cell membrane and then pulling down these 
proteins with, for example, Avidin UltraLink Resin by Thermoscientific. The samples 
can then be used for Western blot analysis, thereby allowing us to quantify changes to 
the GABAA receptor surface expression. Since we only measured changes out to 7 days 
following hypoxia and sIPSC frequency alone remained decreased it is possible and 
probable that this remains decreased. If sIPSC frequency remains decreased persistently 
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especially into adulthood it could provide novel pharmacotherapy.  
For example, drugs that are known to increase the firing rate of interneurons, i.e. 
through interacting with HCN channels and effecting IH, could provide an alternative 
pharmacological therapy. Interestingly, we recently reported that that the anticonvulsant 
drugs Lamotrigine and Gabapentin increased the excitability of presumed inhibitory s.o. 
non-pyramidal neurons via enhancement of IH, and that this effect was associated with 
increased spontaneous synaptic inhibition of CA1 pyramidal neurons, possibly 
identifying an additional anti-convulsant mechanism that was previously unknown  
(Peng et al 2010, 2011).  
Much work must be done to begin to understand the mechanisms underlying 
decreased GABAergic inhibition following perinatal hypoxia-inducing seizures. We 
have just discovered that persistently decreased GABAergic inhibition may be a 
proepileptogenic mechanism  providing us with further rationale to explore this area in 
this animal model of acquired epilepsy. 
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APPENDIX A 
Appendix A: Illustration of Miniature Postsynaptic Currents (mIPSCs) 
A.
 
 
B. 
 
 
Appendix A: A. Miniature Inhibitory Post Synaptic Currents. A basic set of events 
occur that result in miniature inhibitory post synaptic currents that are mediated by 
GABA and synaptically located GABAA receptors. 1) Tetrodotoxin blocks action 
potential firing of interneurons and allows 2) only random fusion of GABA containing 
vesicles releasing significantly less GABA into the synapse where 3) less GABAA 
receptors are activated post-synaptically leading to 4) miniature inhibitory post-synaptic 
currents called mIPSCs. B.  example whole-cell voltage clamp trace of mIPSCs recorded 
from hippocampal area CA1 pyramidal neurons. 
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APPENDIX B 
Appendix B: Illustration of Spontaneous Postsynaptic Currents (sIPSCs) 
A. 
 
B.
 
 
Appendix B: A. Spontaneous Inhibitory Post Synaptic Currents. 1) Action potential 
firing of interneurons occur in the absence of TTX and allows 2)greater release of 
GABA by calcium dependent mechanisms where 3) greater activation of GABAA 
receptors occur post-synaptically leading to 4)spontaneous inhibitory post-synaptic 
currents called sIPSCs. B. Example whole-cell voltage clamp trace of sIPSCs. 
